Thermo Fisher Scientific Inc. (TMO)
After hours:
| Previous close | 575.80 |
| Open | 568.59 |
| Bid | 552.94 x 800 |
| Ask | 578.58 x 800 |
| Day's range | 560.72 - 576.97 |
| 52-week range | 433.52 - 672.34 |
| Volume | |
| Avg. volume | 1,488,772 |
| Market cap | 223.721B |
| Beta (5Y monthly) | 0.74 |
| PE ratio (TTM) | 26.35 |
| EPS (TTM) | 21.54 |
| Earnings date | 02 Feb 2022 |
| Forward dividend & yield | 1.04 (0.18%) |
| Ex-dividend date | 14 Dec 2021 |
| 1y target est | 692.60 |
- Zacks
Rise in COVID Tests to Boost Thermo Fisher (TMO) Q4 Earnings
With the emergence of the Omicron variant through the Q4 months globally, Thermo Fisher's (TMO) Life-Science Solutions segment is likely to have registered strong top-line contributions.
- Motley Fool
2 No-Brainer Healthcare Stocks to Buy Right Now
When you're looking for stalwart stocks to preserve your portfolio's value while also providing exposure to long-term growth, healthcare businesses can be quite appealing. More importantly, they're both absolutely indispensable for their customers, which gives them staying power. Thermo Fisher Scientific (NYSE: TMO) is a healthcare sector juggernaut, earning its market cap of around $253 billion by producing a galaxy of critical goods and hardware for hospitals, diagnostic clinics, and research institutions.
- Zacks
Top Research Reports for Microsoft, Visa & Cisco
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Visa Inc. (V), and Cisco Systems, Inc. (CSCO).
